Status:
UNKNOWN
Arrhythmogenic Substrate in Primary Cardiomyopathies and/or Channellopathies
Lead Sponsor:
IRCCS Policlinico S. Donato
Conditions:
Cardiomyopathy
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
This study assesses the value of arrhythmogenic substrate identification and elimination by catheter ablation to prevent recurrent ventricular arrhythmias and sudden cardiac death in a series of selec...
Detailed Description
The present study is designed as a prospective single center study. All selected patients with implanted ICD to prevent VT/VF recurrence who are referred to the Arrhythmology Department of San Donato ...
Eligibility Criteria
Inclusion
- Patients affected by cardiomyopathies and/or channellopaties (long QT syndrome and J-wave syndrome) with and without documented family history of BrS;
- Presence of symptoms attributable to VA and/or presenting documented arrhythmic episodes;
- Patients with an ICD already implanted;
- Patients referred to the centre for an electrophysiological study and indication for a potential concomitant radio-frequency catheter ablation (RFA) of ventricular tachycardia (VT) or ventricular fibrillation (VF);
- Age ≥ 18;
- Willingness to attend follow-up examinations;
- Written informed consent for the participation in the trial
Exclusion
- Pregnancy or breast-feeding;
- Life expectancy \< 12 months
Key Trial Info
Start Date :
January 24 2018
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 30 2023
Estimated Enrollment :
35 Patients enrolled
Trial Details
Trial ID
NCT03304847
Start Date
January 24 2018
End Date
December 30 2023
Last Update
October 3 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
IRCCS Policlinico S. Donato
San Donato Milanese, Milano, Italy, 20097